MB
Publicaties op Oncologisch.com
Real-World Endpoints in Stereotactic Body Radiotherapie Trials for Oligoprogression: Beyond Progression-Free Survival and Algehele overleving
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial
Sequentieel Lu-PSMA-617 plus docetaxel versus docetaxel bij mHSPC: UpFrontPSMA fase II
Eenfractie versus multifractie SBRT bij longkanker: SAFRON II langetermijn